These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 20601279)

  • 21. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
    Van Dyke MW
    ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural products as zinc-dependent histone deacetylase inhibitors.
    Tan S; Liu ZP
    ChemMedChem; 2015 Mar; 10(3):441-50. PubMed ID: 25581683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.
    Grozinger CM; Chao ED; Blackwell HE; Moazed D; Schreiber SL
    J Biol Chem; 2001 Oct; 276(42):38837-43. PubMed ID: 11483616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of enzymatically active recombinant class III protein deacetylases.
    North BJ; Schwer B; Ahuja N; Marshall B; Verdin E
    Methods; 2005 Aug; 36(4):338-45. PubMed ID: 16091304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on lysine deacylases targeting the expanding "acylome".
    Olsen CA
    ChemMedChem; 2014 Mar; 9(3):434-7. PubMed ID: 24375937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.
    Madsen AS; Andersen C; Daoud M; Anderson KA; Laursen JS; Chakladar S; Huynh FK; Colaço AR; Backos DS; Fristrup P; Hirschey MD; Olsen CA
    J Biol Chem; 2016 Mar; 291(13):7128-41. PubMed ID: 26861872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
    Hirsch BM; Zheng W
    Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide.
    Hoff KG; Avalos JL; Sens K; Wolberger C
    Structure; 2006 Aug; 14(8):1231-40. PubMed ID: 16905097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-step, nonenzymatic synthesis of O-acetyl-ADP-ribose and analogues from NAD and carboxylates.
    Szczepankiewicz BG; Koppetsch KJ; Perni RB
    J Org Chem; 2011 Aug; 76(16):6465-74. PubMed ID: 21639110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic control by sirtuins and other enzymes that sense NAD
    Anderson KA; Madsen AS; Olsen CA; Hirschey MD
    Biochim Biophys Acta Bioenerg; 2017 Dec; 1858(12):991-998. PubMed ID: 28947253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity.
    Merrick CJ; Duraisingh MT
    Eukaryot Cell; 2007 Nov; 6(11):2081-91. PubMed ID: 17827348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting sirtuin-catalyzed deacylation reactions using ³²P-labeled NAD and thin-layer chromatography.
    Zhu A; Su X; Lin H
    Methods Mol Biol; 2013; 1077():179-89. PubMed ID: 24014407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Sirtuins: Substrate Specificity and Inhibitor Design.
    Rajabi N; Galleano I; Madsen AS; Olsen CA
    Prog Mol Biol Transl Sci; 2018; 154():25-69. PubMed ID: 29413177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: The plant sirtuins.
    Zheng W
    Plant Sci; 2020 Apr; 293():110434. PubMed ID: 32081272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.
    Xia J; Tilahun EL; Kebede EH; Reid TE; Zhang L; Wang XS
    J Chem Inf Model; 2015 Feb; 55(2):374-88. PubMed ID: 25633490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.
    Zheng W
    Mini Rev Med Chem; 2013 Jan; 13(1):132-54. PubMed ID: 22876953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking and binding free energy calculations of sirtuin inhibitors.
    Karaman B; Sippl W
    Eur J Med Chem; 2015 Mar; 93():584-98. PubMed ID: 25748123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity in the Sir2 family of protein deacetylases.
    Buck SW; Gallo CM; Smith JS
    J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.